Vitamin E-coated cellulose acetate dialysis membrane: Long-term effect on inflammation and oxidative stress

Renal Failure

Volumn 32, Issue 3, 2010, Pages 287-293

  Takouli, L ^a   Hadjiyannakos, D ^a   Metaxaki, P ^a   Sideris, V ^b   Filiopoulos, V ^a   Anogiati, A ^b   Vlassopoulos, D ^a  

^a Amalia Fleming Hospital   (Greece)

^b Pendeli Pediatric Hospital   (Greece)

Author keywords

Hemodialysis; Inflammation; Oxidative stress; Vitamin E coated membrane

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; CELLULOSE ACETATE; INTERLEUKIN 6; POLYSULFONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; ANTIOXIDANTS; C-REACTIVE PROTEIN; CELLULOSE; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FREE RADICALS; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; OXIDATIVE STRESS; POLYMERS; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS; SULFONES; SUPEROXIDE DISMUTASE; VITAMIN E;

EID: 77950571041     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860221003615795     Document Type: Article

References (39)

1. Kaysen GA. The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol. 2001;12:1549-1557.
2. Rayner HC, Pisoni RL, Bommer J, et al. Mortality and hospitalization in hemodialysis patients in five European countries: Results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2004;19:108-120. (Pubitemid 38072622)
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
4. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18:1272-1280.
5. Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis. 2001;38:1408.
6. Satoh M, Yamasaki Y, Nagake Y, et al. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int. 2001;59:1943-1950.
7. Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vitamin E-coated polysulphone membrane reduces oxidative stress markers in hemodialysis patients. Nephrol Dial Transplant. 2005;20:2775-2782.
8. Betjes MG, Hoekstra FM, Klepper M, Postma SM, Vaessen LM. Vitamin E-coated dialyzer membranes downregulate expression of monocytes adhesion and co-stimulatory molecules. Blood Purif. 2004;22(6):510-517.
9. Morena M, Gausson V, Mothu N, et al. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile. Blood Purif. 2008;26:300-310.
10. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem. 1996;239:70-76.
11. Cesarone MR, Belgaro G, Carratelli M, et al. A simple test to monitor oxidative stress. Int Angiol. 1999;18:127-130.
12. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524-1538.
13. Jaber BL, Pereira BJ. Biocompatibility of hemodialysis membranes. In: Pereira B, Sayegh M, Blake P, eds. Chronic Kidney Disease, Dialysis and Transplantation: A Companion to Brenner and Rector's The Kidney. 2nd ed. Philadelphia, PA: Elsevier Saunders; 2005:363-387.
14. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
15. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843. (Pubitemid 30165206)
16. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54:627-663.
17. Weinhold B, Bader A, Poli V, Ruther U. Interleukin-6 is necessary, but not sufficient, for induction of the human C-reactive protein gene in vivo. Biochem J. 1997;325:617-621.
18. Lowrie EG. Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dialysis patients. Am J Kidney Dis. 1998;32:S105-S112.
19. Bistrian BR. Role of the systemic inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD. Am J Kidney Dis. 1998;32:S113-S117.
20. Kopple JD. Pathophysiology of protein-energy wasting in chronic renal failure. J Nutr. 1999;129:247S-251S.
21. Nguyen-Khoa T, Massy ZA, De Bandt JP, et al. Oxidative stress and hemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant. 2001; 16:335-340.
22. Handelman GJ, Walter MF, Adhikarla R, et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 2001;59:1960-1966.
23. Himmelfarb J, Kane J, McMonagle E, et al. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 2003;64:978-991.
24. Iseki K, Tozawa M, Yoshi S, Fuyikama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14:1956-1960.
25. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35:469-476.
26. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med. 2000;28:1456-1462.
27. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. Free radicals and phagocytic cells. FASEB J. 1995;9:200-209.
28. Girndt M, Lengler S, Kaul H, Sester U, Sester M, Köhler H. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. Am J Kidney Dis. 2000;35(1):95-104.
29. Azzi A, Boscoboinik D, Hensey C. The protein kinase C family. Eur J Biochem. 1992;208(3):547-557.
30. Mydlík M, Derzsiová K, Rácz O, et al. Vitamin E-coated dialyzer and antioxidant defense parameters: Three-month study. Semin Nephrol. 2004;24(5):525-531.
31. Durak I, Akyol O, Basesme E, Canbolat O, Kavutçu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron. 1994;66(1):76-80.
32. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med. 1996;21(6): 845-853.
33. Boran M, Küçükaksu C, Balk M, Cetin S. Red cell lipid peroxidation and antioxidant system in hemodialysed patients: Influence of recombinant human erythropoietin (r-HuEPO) treatment. Int Urol Nephrol. 1998;30(4):507-512.
34. Zimmermann J, Herrlinger S, Pruy A, Metzeger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648-658.
35. Honda H, Qureshi AR, Heimbürger O, et al. Serum albumin, C-reactive protein, interleukin 6 and Fetuin A as predictors of malnutrition, cardiovascular disease and mortality in ESRD patients. Am J Kidney Dis. 2006;47:139-148.
36. Senol E, Ersoy A, Erdinc S, Sarandol E, Yurtkuran M. Oxidative stress and ferritin levels in hemodialysis patients. Nephrol Dial Transplant. 2008;23:665-672.
37. Menon V, Greene T, Wang X, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005;68:766-772.
38. Paul JL, Sall ND, Soni T, et al. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron. 1993;64(1): 106-109.
39. Mydlík M, Derzsiová K, Rácz O, et al. A modified dialyzer with vitamin E and antioxidant defense parameter. Kidney Int Suppl. 2001;78:S144-S147.